Dr Edward Coughlan. Clinical Director Christchurch Sexual Health Christchurch
|
|
- Shon Hampton
- 5 years ago
- Views:
Transcription
1 Dr Edward Coughlan Clinical Director Christchurch Sexual Health Christchurch 16:30-17:25 WS #48: Mycoplasma Genitalium - The New Black 17:35-18:30 WS #58: Mycoplasma Genitalium - The New Black (Repeated)
2 Christchurch Sexual Health 314 Riccarton Road Mycoplasma genitalium Dr Edward Coughlan Clinical Director
3 Disclosures Educational grants to attend HIV meetings by ViiV
4 M genitalium- History and Biology NZ studies Other Studies of Prevalence and Associations Studies Concerning treatment Who to test,how to test, how to treat
5 History and Biology Initial isolation from 2 of 13 men with urethritis in 1980 Tully,Talyor-Robinson- Lancet 1981;1: Class of Mollicutes Very small No cell wall Very small genome 582,970 base pairs in a circular chromosome,coding for 521 genes
6 Lacks all the genes for amino acid synthesis Found preferentially in the genital tract Morphology flask shaped with a specialised tip structure Good at adhering
7
8
9
10
11 Christchurch Pilot 46 men with diagnosed Urethritis 5 of these positive for M genitalium ( 10.8%) 1 of these had rectal chlamydia at the time of diagnosis,others negative for Gonorrhoea or Chlamydia All had a past history of chlamydia 2 had recurrent or persistent NGU
12 A Case-Control Study of Men with Non-Gonococcal Urethritis at Auckland Sexual Health Service Rates of Isolation of Mycoplasma genitalium Jackie Hilton* Sunita Azariah, Murray Reid
13 Method Men presenting to ASHS with symptoms of urethritis or asymptomatic men were invited to participate in the study. Men were given an information sheet and signed a consent form if they were agreeable to participate
14 Specific Infections Cases Controls X 2 p CT 70 (33.5%) MG 21 (10.0%) 8 (4.0%) 55.4 < (2.0%) 10.1 <0.005 co-infected* 4 (1.9%) - [*included in organism specific totals]
15 Conclusions In this sample the rate of isolation of MG from men with NGU was lowish (10%) The rate of co-infection with CT was very low If not specifically tested for, the 4 controls with MG would not have been detected. MG is a cause of NGU in MSM Azithromycin 1g stat has good efficacy as a treatment for MG BUT NOT ANY MORE
16 Auckland Sexual Health In women who were being screened for an STI Chlamydia trachomatis 10.7% M genitalium 8.4% N gonorrhoea 1.9% -Trichomoniasis 3.5%» Oliphant,Azariah 2013
17 Estimated prevalences in 40 independent studies (27 000) women 7.3% MG in high risk,2.0% low risk CT ( 4.2% ),NG (0.4%) USA
18 Urethritis Inoculation of male chimpanzees resulting in urethritis Brit J of Exp Path 1985,66: M genitalium prevalence in urethritis patients varies from 8% ( urology) to 29% among STD patients M genitalium prevalence in asymptomatic patients varies from 0% ( urology) to 9% among STD patients Uuskula Int J of STD and AIDS 2002;13:79-85
19 Urethritis Persistent urethral inflammation seen in a substantial number of men despite M genitalium eradication Bjornelius STI 2008 ;84:72-76 Relapsing /recurrent urethritis M genitalium +ve, respond initially to doxycycline clinically but still can isolate M gentilium then relapse Mena CID 2009 ;
20 Urethritis Wikstrom and Jenson found 40% of those patients with patients with NCNGU treated with doxycycline who failed treatment were M genitalium positive Wikstom Jensen STI 2006 ;82: Also men with M genitalium more often have urethritis with >10 PMNs/hpf than those with NMGNCNGU. Ie men with urethritis but none of these pathogens
21 Endometritis In this study-detected M genitalium in the cervix,endometrium or both in 9(16% ) of 58 women with histologically confirmed endometritis and in 1 ( 2%) of 57 without endometitritis Cohen Lancet Mar 2,2002,359,pg 765
22 Manhart et al showed women with M genitalium had 3.3 fold greater risk of Mucopurulent cervicitis Manhart JID 2003:187,
23 In contrast, other studies of high-risk female populations have failed to demonstrate an association between M. genitalium detection and cervicitis, despite high M. genitalium detection rates. In one prospective study of 170 women who presented to an STI clinic in France with abnormal vaginal discharge, the prevalence of M. genitalium was 38 percent,.
24 its detection was not associated with signs (erythematous cervix, mucopurulent discharge, or 10 PMNs per high power field in the cervical smear) or symptoms of cervicitis
25 PID M. genitalium can ascend from the lower to upper genital tract after sexual transmission and several studies have observed associations between detection of the organism and clinical signs or symptoms of PID. In a meta-analysis of 10 studies, the pooled OR for PID among women with M. genitalium infection was 2.14(95% CI ) ( UpToDate)
26 In a prospective study of 2246 sexually active female college students, the baseline prevalence of M. genitalium in selfcollected vaginal specimens was low (3.3 percent), and there was a nonsignificant increase in incidence of PID over a 12- month period among women with detectable M. genitalium compared with those in whom it was not detected (risk ratio 2.35, 95% CI ) UPtoDATE
27 M genitalium in major STI syndromes ( J Jensen) Male NGU ++++ Numerous studies shows this association Around 15% of NGU and 20% of NCNGU Treatment failure leads to persistent symptoms Proctitis + Found in 2-5% of MSM, more in australia No obvious correlations
28 Epididymitis + Few trials Female NGU +++ Only in Scandinavia Cervicitis +++ Most studies show an association PID ++ Increasing evidence but?? Proportion of PID caused by M genitalium less than chlamydia
29 BV + Adverse Pregnancy Outcomes + Prevalence is low in pregnant women Male infertility?? Female Infertility + Serological studies Ectopic Pregnancy? Chronic Abdominal Pain?
30 Resistance Azithromycin binds to the 50S subunit of the ribosome ( includes 23S and 5S) =>inhibits translation of mrna => inhibits protein synthesis Resistance can occur with mutations in the 23S rrna gene => inhibit azithromycin binding
31 Resistance In vitro resistance mediated by mutations in the 23 S rrna gene Thought to occur as a result of single dose treatment of 1.0 gram azithromycin» Jensen CID 2008 :47,1546 Level of azithromycin resistance is very important and is influenced by treatment tradition
32
33 Macrolide Resistance
34 M. genitalium antibiotic resistance Resistance development by single base pair change in the 23S rrna gene at the macrolide binding site Nucleotide position A2058 and A2059
35 Melbourne : Looked at individuals with treatment failure using pre and post treatment samples and looked for mutations in 23sRNA gene. All cases (20) of treatment failure had resistant mutations 9 (45%) had this pre and post treatment 11 (55%) had this post only ie induced» Plos Twin et al 2012
36 The development of resistance to the fluoroquinolones has shown to be linked to mutations in the gyr A and par C genes.
37 M. genitalium antibiotic resistance Second-line treatment using fluoroquinolone such as moxifloxacin Resistance development by single base pair change(s) in four genes important in DNA replication DNA gyrase genes gyra and gyrb Topoisomerase genes parc and pare Mutations occur in the quinolone resistance determining region (QRDR) of each gene Step-wise resistance development One mutation = low level resistance 2 or more = high level resistance
38 CE (Conformité Européene marking) = European quality clearance of new microbiological diagnostics M gen Testing Technologies in flux re FDA approval
39 Mycoplasma genitalium: Local Epidemiology
40 Who To Test Men with persistent/ recurrent urethritis, who have failed initial treatment with doxycycline 100mg bd 7/7 Current ongoing contacts of people who test positive for MG Women with persistent PID who have failed standard treatment
41 How to Test Use Speedex platform ( CHL not Southern Community) On request form need to state reason And test = M genitalium PCR Male urine test Female- vulvovaginal swab using the Abbott Multicollect ( may need to send them to SCL collection site)
42
43
44 How to Treat Keeps changing Eg for M genitalium with no resistance 1 gram azithromycin Azithromycin 500mg stat then 250mg for 4 days Now Doxycline 100mg BD for 7 days then Azithromycin 1.0 gram stat then 500mg once a day for 3 days
45 How to Treat No resistance then Doxycline 100mg BD for 7 days then Azithromycin 1.0 gram stat then 500mg once a day for 3 days
46 If macrolide resistance present and azithromycin has been used AND failed Then apply for Special Authority online and use moxifloxacin 400mg for 7 days
47 If macrolide resistance present and azithromycin has NOT been used then need to fax a request for a waiver And use Moxifloxacin for 7 days
48
49 IN all cases a test of cure 4 weeks after treatment completion NO sex until clear test of cure and partner test of cure
50 Refer in any failures after Moxifloxacin IF easier refer in if positive M genitalium test
51 Summary Treat initial urethritis with doxycline if gonorrhoea is unlikely. Don t order M genitalium testing as a screen Refer positives if easier
52
53 Acknowledgements Canterbury Health Laboratories- Julie Creighton, Trevor Anderson.Anja Werno Melbourne (Marcus Chen,Cat Bradshaw) Staff Christchurch Sexual Healthespecially Dr Heather Young
Mycoplasma genitalium:
Mycoplasma genitalium: What is it and why should we care? Lisa E. Manhart, PhD, MPH rwpoll.com uwecho Last Updated: 09-26-2016 uwptc@uw.edu uwptc.org 206-685-9850 Disclosures Service on a scientific advisory
More informationAnswers to those burning questions -
Answers to those burning questions - Ann Avery MD Infectious Diseases Physician-MetroHealth Medical Center Assistant Professor- Case Western Reserve University SOM Medical Director -Cleveland Department
More informationANALYSIS OF MYCOPLASMA GENITALIUM STRAINS ISOLATED FROM PREGNANT WOMEN AT AN ACADEMIC HOSPITAL IN PRETORIA, SOUTH AFRICA
ANALYSIS OF MYCOPLASMA GENITALIUM STRAINS ISOLATED FROM PREGNANT WOMEN AT AN ACADEMIC HOSPITAL IN PRETORIA, SOUTH AFRICA Mafunise M 1, Le Roux MC 1, de Villiers BE 1, Ditsele RMM 1,2 1 Department of Microbiological
More informationMycoplasma genitalium: epidemiology, diagnostics and antimicrobial resistance
Mycoplasma genitalium: epidemiology, diagnostics and antimicrobial resistance Cécile Bébéar USC EA 3671 Mycoplasmal and chlamydial infections in humans INRA - University of Bordeaux Bordeaux University
More informationMYCOPLASMA GENITALIUM A PRACTICAL GUIDE
MYCOPLASMA GENITALIUM A PRACTICAL GUIDE DR JENNY HAYWARD FRANZCOG FACHSHM NEW ZEALAND SEXUAL HEALTH CONFERENCE SATURDAY 9 TH SEPTEMBER 1 ACKNOWLEDGE FRUSTRATIONS AWARENESS EVOLVING AREA TESTING OFTEN MULTIPLE
More informationClinical Guidelines Update (aka Know Your NAATs)
Clinical Guidelines Update (aka Know Your NAATs) WARNING: contains adult themes, sexual references and pictures that may be disturbing! Dr Heather Young Christchurch Sexual Health Centre heather.young@cdhb.health.nz
More informationMG and PID. Dr Jeannie Oliphant Dr Sunita Azariah Auckland Sexual Health Service
MG and PID Dr Jeannie Oliphant Dr Sunita Azariah Auckland Sexual Health Service MG and NGNCU Strong relationship between M. genitalium and NGNCU Taylor-Robinson et al. 2011 Clin. Micro. Rev;24(3):498 MG
More informationSTIs: Practical Aspects of Management
STIs: Practical Aspects of Management Dr Heather Young FAChSHM DipPH Christchurch Sexual Health heathery@xtra.co.nz 027 343 4963 Sexually Transmitted Infections BACTERIAL STIs: CHLAMYDIA GONORRHOEA SYPHILIS
More informationGenital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management. William M. Geisler M.D., M.P.H. University of Alabama at Birmingham
Genital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management William M. Geisler M.D., M.P.H. University of Alabama at Birmingham Chlamydia and Gonorrhea Current Epidemiology Chlamydia Epidemiology
More information6/11/15. BACTERIAL STDs IN A POST- HIV WORLD. Learning Objectives. How big a problem are STIs in the U.S.?
BACTERIAL STDs IN A POST- HIV WORLD Tracey Graney, PhD, MT(ASCP) Monroe Community College Learning Objectives Describe the epidemiology and incidence of bacterial STDs in the U.S. Describe current detection
More informationAdvances in STI diagnostics. Dr Paddy Horner Consultant Senior Lecturer University of Bristol
Advances in STI diagnostics Dr Paddy Horner Consultant Senior Lecturer University of Bristol Advances in STI diagnostics Rapid expansion in on-line STI testing Outstripping NHS expert advice Increasing
More informationThesis for doctoral degree (Ph.D.) 2010 CLINICAL ASPECTS OF MYCOPLASMA GENITALIUM INFECTION Eva Björnelius. Eva Björnelius
Thesis for doctoral degree (Ph.D.) 2010 Thesis for doctoral degree (Ph.D.) 2010 CLINICAL ASPECTS OF MYCOPLASMA GENITALIUM INFECTION Eva Björnelius CLINICAL ASPECTS OF MYCOPLASMA GENITALIUM INFECTION Eva
More informationScottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL) User Manual Jan 2018
Scottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL) User Manual Jan 2018 Page 1 Contents 1 Introduction Page 3 2 Contact details Page 4 3 Opening hours Page 4 4 Services provided
More informationMycoplasma genitalium: An Important Consideration in Male Urethritis DR. ALEXANDRA CARLE
Mycoplasma genitalium: An Important Consideration in Male Urethritis DR. ALEXANDRA CARLE Overview Introduction to Mycoplasma genitalium Audit Objectives Standards Results Reflection AFPHM learning objectives
More informationWHAT DO U KNOW ABOUT STIS?
WHAT DO U KNOW ABOUT STIS? Rattiya Techakajornkeart MD. Bangrak STIs Cluster, Bureau of AIDS, TB and STIs, Department of Disease Control, MOPH, Thailand SEXUALLY TRANSMITTED INFECTIONS? STIs Infections
More informationManagement of NGU (Non-gonococcal urethritis)
Management of NGU (Non-gonococcal urethritis) First line Doxycycline 100mg po bd for 7 days (contra-indicated in pregnancy) Alternative regimens Azithromycin 1G po stat Azithromycin 500mg po stat, then
More informationSTIs- REVISION. Prof A A Hoosen
STIs- REVISION Prof A A Hoosen Department of Medical Microbiology, Faculty of Health Sciences, University of Pretoria and the NHLS Microbiology Tertiary Laboratory at the Pretoria Academic Hospital Complex
More informationMG an emerging sexually transmitted infection
CATIE-News CATIE s bite-sized HIV and hepatitis C news bulletins. MG an emerging sexually transmitted infection 9 October 2013 The bacterium Mycoplasma genitalium (MG) is sexually transmitted and can cause
More informationSTI & HIV screening in Primary Care. Dr Paddy Horner Consultant Senior Lecturer University of Bristol Annette Billing Public Health, Bristol Council
STI & HIV screening in Primary Care Dr Paddy Horner Consultant Senior Lecturer University of Bristol Annette Billing Public Health, Bristol Council Outline Why Screen Advances in diagnostics how can we
More informationT he organisms Chlamydia trachomatis and Neisseria gonorrhoeae
458 MYCOPLASMA GENITALIUM Mycoplasma genitalium: prevalence, clinical significance, and transmission C Anagrius, B Loré, J S Jensen... See end of article for authors affiliations... Correspondence to:
More informationWhat's the problem? - click where appropriate.
STI Tool v 1.9 @ 16/11/2017 What's the problem? - click where appropriate. Male problems: screening urethral symptoms proctitis in gay men lumps or swellings ulcers or sores skin rash and/or itch Female
More informationIndex. Infect Dis Clin N Am 19 (2005) Note: Page numbers of article titles are in boldface type.
Infect Dis Clin N Am 19 (2005) 563 568 Index Note: Page numbers of article titles are in boldface type. A Abstinence in genital herpes management, 436 Abuse sexual childhood sexual behavior effects of,
More informationSexually Transmi/ed Diseases
Sexually Transmi/ed Diseases Chapter Fourteen 2013 McGraw-Hill Higher Education. All rights reserved. Also known as sexually transmitted infections The Major STDs (STIs) HIV/AIDS Chlamydia Gonorrhea Human
More informationSexually Transmitted Infection Treatment and HIV Prevention
Sexually Transmitted Infection Treatment and HIV Prevention Toye Brewer, MD Co-Director, Fogarty International Training Program University of Miami Miller School of Medicine STI Treatment and HIV Prevention.
More informationGlobal challenge of antibiotic-resistant Mycoplasma genitalium. by author. Sabine Pereyre
Global challenge of antibiotic-resistant Mycoplasma genitalium Sabine Pereyre USC EA 3671 Mycoplasmal and chlamydial infections in humans INRA - University of Bordeaux -Bordeaux University Hospital National
More informationNew diagnostic tests for sexually transmitted infections. Jens Van Praet 30/11/2018
New diagnostic tests for sexually transmitted infections Jens Van Praet 30/11/2018 Introduction Data from our national microbiological labs suggest STIs are an important clinical issue Correlation with
More informationInternationell utblick STI/HIV i världen
Internationell utblick STI/HIV i världen Magnus Unemo, PhD, Assoc. Professor, Director Swedish Reference Laboratory for Pathogenic Neisseria, Department of Laboratory Medicine, Microbiology Örebro University
More informationMycoplasma Genitalium: Get to Know the Hidden STI
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/womens-health-update/mycoplasma-genitalium-get-to-know-hiddensti/9501/
More informationM ycoplasma genitalium was isolated originally from the
289 ORIGINAL ARTICLE Symptomatic urethritis is more prevalent in men infected with Mycoplasma genitalium than with Chlamydia trachomatis L Falk, H Fredlund, J S Jensen... See end of article for authors
More informationChlamydia Trachomatis and Neisseria Gonorrhoeae. Khalil G. Ghanem, MD Johns Hopkins University
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
More informationEpidemiological and clinical rationale for screening and diagnosis of Mycoplasma genitalium infections
Epidemiological and clinical rationale for screening and diagnosis of Mycoplasma genitalium infections CHRIS L. MCGOWIN, RODNEY E. ROHDE, GERALD REDWINE LEARNING OBJECTIVES 1. Discuss the historical and
More informationEmergence et impact clinique de la résistance aux antibiotiques chez Chlamydia trachomatis, Neisseria gonorrhoeae, les mycoplasmes
Emergence et impact clinique de la résistance aux antibiotiques chez Chlamydia trachomatis, Neisseria gonorrhoeae, les mycoplasmes Cécile Bébéar French National Center for bacterial STIs Bordeaux University
More informationToward global prevention of sexually transmitted infections: the need for STI vaccines
Training Course in Sexual and Reproductive Health Research 2017 Module: Sexually transmitted infections, HIV/AIDS Toward global prevention of sexually transmitted infections: the need for STI vaccines
More informationGynaecology. Pelvic inflammatory disesase
Gynaecology د.شيماءعبداألميرالجميلي Pelvic inflammatory disesase Pelvic inflammatory disease (PID) is usually the result of infection ascending from the endocervix causing endometritis, salpingitis, parametritis,
More informationNothing to disclose.
Update on Diagnosis and Treatment Lisa Winston, MD University of California, San Francisco/ Zuckerberg San Francisco General Nothing to disclose. 1 This talk will be a little depressing Rising incidence
More informationMYCOPLASMA GENITALIUM: CLINICAL CHARACTERISTICS, RISK FACTORS AND ADVERSE PREGNANCY OUTCOME. Vanessa L. Short. BS, Pennsylvania State University, 2002
MYCOPLASMA GENITALIUM: CLINICAL CHARACTERISTICS, RISK FACTORS AND ADVERSE PREGNANCY OUTCOME by Vanessa L. Short BS, Pennsylvania State University, 2002 MPH, University of Pittsburgh, 2005 Submitted to
More informationOBJECTIVES. Emerging Laboratory Diagnostic Options for Sexually-transmitted Infections
Emerging Laboratory Diagnostic Options for Sexually-transmitted Infections OBJECTIVES I. Appreciate the changing epidemiology of trichomoniasis and clinician ordering patterns on the basis of improved
More informationRISING TO THE GLOBAL CHALLENGE... GONORRHOEA, SYPHILIS AND OTHER BUGS
RISING TO THE GLOBAL CHALLENGE... GONORRHOEA, SYPHILIS AND OTHER BUGS Warning: contains sexual themes and references! Dr Heather Young Christchurch Sexual Health Centre heather.young@cdhb.health.nz Updates
More informationJulie Nelson RNC/WHNP-BC Epidemiology NURS 6313
Julie Nelson RNC/WHNP-BC Epidemiology NURS 6313 Chlamydia Most frequently reported bacterial STI in the US In 2006, In U.S. 1,030,911 cases were reported. Estimated 2,291,000 infections in 14-39 year olds.
More informationEmerging Laboratory Diagnostic Options for Sexually-transmitted Infections
Emerging Laboratory Diagnostic Options for Sexually-transmitted Infections Erik Munson Wheaton Franciscan Laboratory Marquette University Milwaukee, Wisconsin 1 OBJECTIVES I. Appreciate the changing epidemiology
More informationSTDs and Hepatitis C
STDs and Hepatitis C Catherine S. O Neal, MD Assistant Professor of Clinical Medicine, Infectious Diseases Louisiana State University Health Sciences Center March 3, 2018 Objectives Review patient risk
More informationChlamydia Curriculum. Chlamydia. Chlamydia trachomatis
Chlamydia Chlamydia trachomatis 1 Learning Objectives Upon completion of this content, the learner will be able to: 1. Describe the epidemiology of chlamydial infection in the U.S. 2. Describe the pathogenesis
More informationPelvic Inflammatory Disease (PID) Max Brinsmead PhD FRANZCOG July 2011
Pelvic Inflammatory Disease (PID) Max Brinsmead PhD FRANZCOG July 2011 This talk What is Pelvic Inflammatory Disease? Why it is important How it is spread Diagnosis Treatment Prevention What is PID? Inflammation
More information2018 BASHH UK national guideline for the management of infection with Mycoplasma genitalium
01 BASHH UK national guideline for the management of infection with Mycoplasma genitalium 1 1 1 1 1 1 1 Suneeta Soni, Paddy Horner, Michael Rayment, Nicolas Pinto-Sander, Nadia Naous, Andy Parkhouse, Darren
More informationBe sure! Your Power for Health. PelvoCheck CT/NG Your test kit for Chlamydia trachomatis screening and Neisseria gonorrhoeae infections
Your Power for Health Laboratory Information CT/NG DNA-Chip Be sure! Your test kit for Chlamydia trachomatis screening and Neisseria gonorrhoeae infections is part of the ocheck product line from Greiner
More informationChlamydia trachomatis IgG antibodies. TAT: 7-10 days, Germany. Units: U/ml
Chlamydia General: Chlamydia belong to small bacteria, they grow obligatorily intracellularly and some Chlamydia belong to sexually transmitted diseases (STDs). Transmission also occurs through animals.
More informationRésistance bactérienne au cours des Infections Sexuellement Transmissibles Cécile Bébéar
Résistance bactérienne au cours des Infections Sexuellement Transmissibles Cécile Bébéar French Na*onal Center for bacterial STIs Bordeaux University hospital, Bordeaux, France University of Bordeaux,
More informationBacterial STIs, Research and Development, Statens Serum Institut, Copenhagen, *Corresponding Author:
JCM Accepts, published online ahead of print on 18 August 2010 J. Clin. Microbiol. doi:10.1128/jcm.00232-10 Copyright 2010, American Society for Microbiology and/or the Listed Authors/Institutions. All
More informationSexually transmitted infections (in women)
Sexually transmitted infections (in women) Timothy Kremer, MD Assistant Professor, Department of Obstetrics and Gynecology University of North Texas Health Science Center Last official CDC guidelines:
More informationNotifiable Sexually Transmitted Infections 2009 Annual Report
Notifiable Sexually Transmitted Infections 29 Annual Report 21 Government of Alberta Alberta Health and Wellness, Surveillance and Assessment Send inquiries to: Health.Surveillance@gov.ab.ca Notifiable
More informationLearning Objectives. STI Update. Case 1 6/1/2016
Learning Objectives STI Update June 16 th, 2016 Madhu Choudhary, MD. FIDSA Assoc. Prof of Medicine Albany Medical College Review screening recommendations for STI in different patient populations Describe
More informationUPDATE MOLECULAR DIAGNOSTICS IN SEXUAL HEALTH. Dr Arlo Upton Clinical Microbiologist Labtests Auckland
UPDATE MOLECULAR DIAGNOSTICS IN SEXUAL HEALTH Dr Arlo Upton Clinical Microbiologist Labtests Auckland Talk outline Chlamydia trachomatis NAAT What does a positive test mean Interpreting low level positives
More informationEmerging Issues in STDs and Resistance
Emerging Issues in STDs and Resistance Toye H. Brewer, MD Asst. Professor of Clinical Medicine University of Miami School of Medicine Co-Director- Fogarty International Training Program Outline Syphilis-
More informationA healthy respect for Sexual Health. Dee Archbold CNC Princess Alexandra Sexual Health
2018 A healthy respect for Sexual Health Dee Archbold CNC Princess Alexandra Sexual Health Princess Alexandra Sexual Health (PASH) Sexual health service for Metro South (estimated >1million residents and
More informationProfessor Jonathan Ross. Dr Melinda Tenant-Flowers. University Hospitals Birmingham NHS Trust. King s College Hospital NHS Foundation Trust, London
THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014 Professor Jonathan Ross University Hospitals Birmingham NHS Trust Dr Melinda Tenant-Flowers King s College Hospital NHS Foundation Trust, London 1-4 April
More informationNovos desafios para controlar as infecções sexualmente transmissíveis [New Challenges in Managing Sexually Transmitted Infections]
Novos desafios para controlar as infecções sexualmente transmissíveis [New Challenges in Managing Sexually Transmitted Infections] Khalil Ghanem, MD, PhD Associate Professor of Medicine Directors, STD/HIV/TB
More informationSexually transmitted infections
Sexually transmitted infections Dr Caroline CHARLIER-WOERTHER Université Paris Descartes Paris, France Learning objectives Counsel patients about the risk of STD Know how to diagnose and treat a sexuallytransmitted
More informationOutline. Trichomoniasis: Testing and Treatment Update. What s in a name? From the Greek: trichos, hair monas, unit, single
Trichomoniasis: Testing and Treatment Update Arlene C. Sena, MD, MPH Medical Director, Durham County Health Department Associate Professor, University of North Carolina Infectious Diseases Outline Epidemiology
More information5/1/2017. Sexually Transmitted Diseases Burning Questions
Sexually Transmitted Diseases Burning Questions Jeffrey D. Klausner, MD, MPH Professor of Medicine and Public Health University of California Los Angeles Los Angeles, California FORMATTED: 04-03-17 Financial
More informationAdvances in Sexual Health
Advances in Sexual Health Dr. Suneeta Soni 18 April 2018 Advances in STI Testing Treatment Prevention Lancet Infectious Diseases Commission Lancet Infect Dis 2017; 17: e235 79 Current shortfalls Access
More informationProfessor Jonathan Ross
SECOND JOINT CONFERENCE OF BHIVA AND BASHH 2010 Professor Jonathan Ross Whittall Street Clinic, Birmingham COMPETING INTEREST OF FINANCIAL VALUE > 1,000: Speaker Name Statement Professor Ross has received
More informationThe objectives of this presentation are; to increase awareness of the issue of antimicrobial resistant gonorrhea, and to inform primary care and
1 Antimicrobial resistant gonorrhea is an emerging public health threat that needs to be addressed. Neisseria gonorrhoeae is able to develop resistance to antimicrobials quickly. Effective antibiotic stewardship
More informationGUIDELINES FOR THE MANAGEMENT OF SEXUALLY TRANSMITTED INFECTIONS
WHO/HIV_AIDS/2001.01 WHO/RHR/01.10 Original: English Distr.: General GUIDELINES FOR THE MANAGEMENT OF SEXUALLY TRANSMITTED INFECTIONS World Health Organization Copyright World Health Organization 2001.
More informationSTI Indicators by STI
STI Indicators by STI Table of Contents pg. 2 Sexual History pg. 3-4 Syphilis pg. 5-6 Gonorrhea pg. 7-9 Chlamydia pg. 10 HIV/PrEP 1 Sexual History Comprehensive Sexual History Elements Percentage of patients
More informationChlamydia and pregnancy
Chlamydia and pregnancy Bertille de Barbeyrac NRC Chlamydia Infections, Bordeaux, France Infectious Diseases in Pregnant Women, Fetuses and Newborns, ESCMID Postgraduate Education Course 3-7 October 2010,
More informationSTI control. Dr. Jane Morgan Hamilton Sexual Health Clinic
STI control Dr. Jane Morgan Hamilton Sexual Health Clinic Overview STI control in theory NZ s reality Where to from here? STI control framework R0=ßcD R0 = reproductive rate; the rate at which infection
More information25/02/2016. New onset low abdominal pain in women of reproductive age. New onset low abdominal pain: why it matters?
New onset in women of reproductive age Dr Deborah Bateson Medical Director Family Planning NSW Chair Australasian Sexual Health Alliance why it matters? Can be fatal (consider ectopic pregnancy in all
More informationAntimicrobial chemotherapy of Mycoplasma genitaliumpositive. urethritis. Review
For reprint orders, please contact reprints@expert-reviews.com Antimicrobial chemotherapy of Mycoplasma genitaliumpositive non-gonococcal urethritis Expert Rev. Anti Infect. Ther. 10(7), 791 803 (2012)
More information2014 CDC GUIDELINES CHLAMYDIA & GONORRHEA DIAGNOSTICS. Barbara Van Der Pol, PhD, MPH University of Alabama at Birmingham
2014 CDC GUIDELINES CHLAMYDIA & GONORRHEA DIAGNOSTICS Barbara Van Der Pol, PhD, MPH University of Alabama at Birmingham DISCLOSURES Honorarium, Speaking Fees or Research Support Atlas Genetics BD Diagnostics
More informationTDL Sexual Health 2019
TDL Sexual Health 019 Sexual Health Screening services continue to become easier to access for everyone, with testing and results becoming available more quickly through both private, NHS clinics, and
More informationTesting, Treating and Managing STIs Dr Jean Irvine
Testing, Treating and Managing STIs Dr Jean Irvine 1 Chlamydia 2 3 Chlamydia: key facts Intracellular bacterial infection Sexually transmitted: Vaginal sex Anal sex?oral sex Most common bacterial STI in
More informationEfficacy of Antimicrobial Therapy for Mycoplasma genitalium Infections
SUPPLEMENT ARTICLE Efficacy of Antimicrobial Therapy for Mycoplasma genitalium Infections Lisa E. Manhart, 1,3 Jørgen Skov Jensen, 4 Catriona S. Bradshaw, 5 Matthew R. Golden, 2,3 and David H. Martin 6
More informationSexually Transmitted Diseases. Summary of CDC Treatment Guidelines
DC 2015 Sexually Transmitted Diseases Summary of CDC Treatment Guidelines These summary guidelines reflect the June 2015 update to the 2010 CDC Guidelines for Treatment of Sexually Transmitted Diseases.
More informationSTI Diagnostics Redesign. HVS and Chlamydia Resource Pack
Important! 1. This information is intended to support practitioners in the management of common sexual health problems and it is therefore essential that each doctor and nurse receives a copy. 2. Future
More informationWomen s Sexual Health: STI and HIV Screening. Barbara E. Wilgus, MSN, CRNP STD/HIV Prevention Training Center at Johns Hopkins
Women s Sexual Health: STI and HIV Screening Barbara E. Wilgus, MSN, CRNP STD/HIV Prevention Training Center at Johns Hopkins I have no disclosures! Review most recent rates of STIs and HIV across the
More information9. Sorting out pelvic inflammatory disease
Sorting out STIs 31 PART-WORK The ninth in a series of articles on diagnosing and managing genitourinary infections 9. Sorting out pelvic inflammatory disease NINA VON KNORRING AND JANET WILSON Pelvic
More informationStephanie. STD Diagnosis and Treatment. STD Screening for Women. Physical Exam. Cervix with discharge from os
STD Diagnosis and Treatment Ina Park, MD, MS STD Control Branch, California Department of Public Health California STD/HIV Prevention Training Center Stephanie 23 year-old female presents for contraception,
More informationRefocussing on STI management to impact HIV prevention
Refocussing on STI management to impact HIV prevention Koleka Mlisana Head: Medical Microbiology (UKZN & NHLS) 14 June 2017: SA AIDS Conference NSP 2017 2022 Objectives Goal 1:Accelerate preventioninorder
More informationClinical correlates and prevalence among women with Mycoplasma genitalium and Chlamydia trachomatis
Clinical correlates and prevalence among women with Mycoplasma genitalium and Chlamydia trachomatis infection visiting a sexual health centre in Sweden Hanna Abäck Carina Bjartling Verksamhetsområde Kvinnosjukvård
More informationRETURN OF THE CLAP: Emerging Issues in Gonorrhea Management and Antibiotic Resistance
RETURN OF THE CLAP: Emerging Issues in Gonorrhea Management and Antibiotic Resistance Ina Park, MD, MS University of California San Francisco California Prevention Training Center DISCLOSURE No Relevant
More informationUpdate on Sexually Transmitted Infections among Persons Living with HIV
Update on Sexually Transmitted Infections among Persons Living with HIV Stephen A. Berry, MD PhD Assistant Professor of Medicine Johns Hopkins University Division of Infectious Diseases Abbreviations and
More informationMycoplasma genitalium in asymptomatic patients implications for screening
Mycoplasma genitalium in asymptomatic patients implications for screening Jonathan Ross, Louise Brown, Pamela Saunders, Sarah Alexander To cite this version: Jonathan Ross, Louise Brown, Pamela Saunders,
More information4. RED AND BLUE TOP COLLECTION SWABS WILL NO LONGER BE SUPPLIED FOR BACTERIAL CULTURE
Laboratory Testing Update Specimen Transport Changes dated 12-24-14 SEH Laboratory is making significant changes to specimen transports! The Laboratory is introducing new testing platforms along with working
More informationDisclosures. What s New in the 2015 CDC STD Treatment Guidelines. Outline. None
Disclosures None What s New in the 2015 CDC STD Treatment Guidelines Ina Park, MD, MS California STD/HIV Prevention Training Center UCSF Dept of Family and Community Medicine STD Control Branch California
More informationSeveral of the most common STDs are often asymptomatic. Asymptomatic
What Are STDs? Several of the most common STDs are often asymptomatic. Asymptomatic Individuals show no symptoms, or the symptoms are mild and disappear after the onset of the infection Common STDs There
More informationReviewing Sexual Health and HIV NM2715
Reviewing Sexual Health and HIV NM2715 Learning objectives To observe and learn from a case study. What happens to a couple who attend a GUM clinic, for screening and subsequent treatment? Revision of
More informationSexually Transmitted Infections in the Adolescent Population. Abraham Lichtmacher MD FACOG Chief of Women s Services Lovelace Health System
Sexually Transmitted Infections in the Adolescent Population Abraham Lichtmacher MD FACOG Chief of Women s Services Lovelace Health System STI in the Adolescent High school students nationwide, 34.2% were
More informationTrends in Reportable Sexually Transmitted Diseases in the United States, 2007
Trends in Reportable Sexually Transmitted Diseases in the United States, 2007 National Surveillance Data for Chlamydia, Gonorrhea, and Syphilis Sexually transmitted diseases (STDs) remain a major public
More informationSexually Transmissible Infections (STI) and Blood-borne Viruses (BBV) A guide for health promotion workers
Sexually Transmissible Infections (STI) and Blood-borne Viruses (BBV) A guide for health promotion workers Sexual & Reproductive Health Western Australia Chlamydia (bacterial infection) Unprotected vaginal
More informationPCR detection and prevalence of Mycoplasma genitalium
Faculty of Technology and Science Biomedical Sciences Andreas Edberg PCR detection and prevalence of Mycoplasma genitalium Karlstad University Studies 2010:11 Andreas Edberg PCR detection and prevalence
More informationOriginal article. Office of Disease Prevention and Control, region 10 Chiang Mai, 2 Sanpatong Hospital, 3
Original article A retrospective study of relationship between white blood cell counts in cervical discharge and Chlamydial cervicitis among young adults: is the simple microscope an alternative method
More informationSexually Transmitted Infections: New Tests, New Guidelines
Sexually Transmitted Infections: New Tests, New Guidelines Michael S. Policar, MD, MPH UCSF Ob, Gyn, and Reproductive Sciences No disclosures for this lecture Value of STI Screening and Testing Benefits
More informationWhat you need to know to: Keep Yourself SAFE!
What you need to know to: Keep Yourself SAFE! What are sexually transmitted diseases (STDs)? How are they spread? What are the different types of STDs? How do I protect myself? STDs are infections or diseases
More informationSexually Transmitted Diseases. Chlamydial. infection. Questions and Answers
Sexually Transmitted Diseases Chlamydial infection Questions and Answers What is chlamydial infection? It is a sexually transmitted infection caused by the bacteria Chlamydia trachomatis, being one of
More informationTRICHOMONAS VAGINALIS
TRICHOMONAS VAGINALIS What s New: There are no changes to this guideline. Introduction Trichomonas vaginalis (TV) is a flagellated protozoan that is a parasite of the genital tract. Due to site specificity,
More informationPELVIC INFLAMMATORY DISEASE (PID)
PELVIC INFLAMMATORY DISEASE (PID) DEFINITION Pelvic inflammatory disease is an infection of the female upper genital tract that involves any combination of the uterus, endometrium, ovaries, fallopian tubes,
More informationLes mycoplasmes urogénitaux : des agents d IST?
Les mycoplasmes urogénitaux : des agents d IST? Sabine Pereyre USC EA 3671 Mycoplasmal and chlamydial infections in humans INRA - University of Bordeaux Bordeaux University Hospital National French Reference
More informationMANAGEMENT OF ACUTE PELVIC INFLAMMATORY DISEASE
WOMEN AND NEWBORN HEALTH SERVICE CLINICAL GUIDELINES SECTION C: GUIDELINES RELEVANT TO GYNAECOLOGY 6.1 ABDOMINAL / PELVIC PAIN 6.1 ACUTE PAIN Authorised by: OGCCU 6.1.3 TREATMENT 6.1.3.1 MANAGEMENT OF
More informationGONORRHEA; ACUTE Does Not Include Chronic Gonorrhea
1 ID 13 GONORRHEA; ACUTE Does Not Include Chronic Gonorrhea Background This case definition was developed in 2013 by the Armed Forces Health Surveillance Center (AFHSC) for the purpose of epidemiological
More informationCategories of STI Screening and Testing Routine screening Population based risk factors Targeted screening Personal behavioral risk factors Contact te
Sexually Transmitted Infections: New Tests, New Guidelines Michael S. Policar, MD, MPH UCSF Ob, Gyn, and Reproductive Sciences No disclosures for this lecture Value of STI Screening and Testing Benefits
More information